US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Mira Pharma

0.7510

+0.03144.36%

Volume:86.25K

Turnover:64.03K

Market Cap:31.45M

PE:-0.54

High:0.7592

Open:0.7300

Low:0.7222

Close:0.7196

52wk High:2.45

52wk Low:0.6000

Shares:41.88M

Float Shares:34.94M

Volume Ratio:1.13

T/O Rate:0.25%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-1.3802

EPS(LYR):-1.3505

ROE:-217.12%

ROA:-129.55%

PB:3.85

PE(LYR):-0.56

Loading ...

Overview Company News Filings

MIRA Pharmaceuticals Initiated at Buy by Maxim Group

MIRA advances Ketamir-2 Phase 2a neuropathy program

Mira advances Ketamir-2 to chemotherapy-induced peripheral neuropathy

MIRA Pharmaceuticals Submits Ketamir-2 Phase 2a CIPN Protocol for IRB Review After FDA Feedback

Mira Pharmaceuticals - Targets Site Initiation for Phase 2a Ketamir-2 Study in Q1 2027

THOMSON REUTERS

Mira Pharmaceuticals - Submits Phase 2a Protocol for Ketamir-2 in Cipn to Irb After FDA Review

THOMSON REUTERS

Mira Pharmaceuticals Advances Ketamir-2 to Phase 2a in Chemotherapy-Induced Peripheral Neuropathy (Cipn) Following FDA Review

THOMSON REUTERS

Mira Pharmaceuticals initiated with a Buy at Maxim

Mira Pharmaceuticals Inc : Maxim Group Initiates Coverage with Buy Rating; Target Price $3.5

THOMSON REUTERS

Mira Pharmaceuticals Holds Annual Shareholder Meeting with 63.06% of Shares Represented

Mira Pharmaceuticals - Targets Ind Application Submission for Mira-55 to FDA in Q1 2027

THOMSON REUTERS

MIRA Pharmaceuticals Advances Non-Opioid Oral MIRA-55 for Inflammatory Pain Toward IND

Mira Pharmaceuticals Q2 2026 Net Loss Narrows to $1.21 Million; Revenue Remains no Revenue

Mira Pharma Reports Positive 7-Day Dog Toxicokinetic Study Results for Obesity Drug Candidate SKNY-1

MIRA Pharmaceuticals Receives Nasdaq Minimum Bid Price Notice

Mira Pharmaceuticals Risks NASDAQ Delisting After Shares Fall Below $1 Bid Price Requirement

Mira Pharmaceuticals provides update on MIRA-55, SKNY-1

Mira Pharmaceuticals Advances Mira-55 Toward IND-enabling Studies After Completing Exploratory Tox Dosing in Rats, Dogs

MIRA Pharmaceuticals Progresses MIRA-55 and SKNY-1 Toward IND-Enabling Studies

Mira Pharmaceuticals Announces Annual Shareholder Meeting

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigerfiesta.com/stock/MIRA/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"MIRA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MIRA\",,,,,undefined,":{"symbol":"MIRA","market":"US","secType":"STK","nameCN":"Mira Pharma","latestPrice":0.751,"timestamp":1789667520511,"preClose":0.7196,"halted":0,"volume":86251,"delay":0,"changeRate":0.04363535297387435,"floatShares":34944200,"shares":41876087,"eps":-1.3802,"marketStatus":"Trading","change":0.0314,"latestTime":"09-17 13:52:04 EDT","open":0.73,"high":0.7592,"low":0.7222,"amount":64028.56181403,"amplitude":0.051417,"askPrice":0.7511,"askSize":200,"bidPrice":0.7461,"bidSize":87,"shortable":3,"etf":0,"ttmEps":-1.3802,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1789675200000},"marketStatusCode":2,"adr":0,"listingDate":1691035200000,"exchange":"NASDAQ","adjPreClose":0.7196,"preHourTrading":{"tag":"盘前","latestPrice":0.7461,"preClose":0.7196,"latestTime":"09:11 EDT","volume":4246,"amount":3249.3508564,"timestamp":1789650702100,"change":0.0265,"changeRate":0.036826,"amplitude":0.082685},"postHourTrading":{"tag":"盘后","latestPrice":0.7104,"preClose":0.7196,"latestTime":"18:15 EDT","volume":2328,"amount":1676.3982,"timestamp":1789596951672,"change":-0.0092,"changeRate":-0.012785,"amplitude":0.027237},"volumeRatio":1.130047},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MIRA\",,,,,undefined,":{"symbol":"MIRA","floatShares":34944200,"roa":"-129.55%","roe":"-217.12%","lyrEps":-1.350504,"volumeRatio":1.130047,"shares":41876087,"dividePrice":0,"high":0.7592,"amplitude":0.051417,"preClose":0.7196,"low":0.7222,"week52Low":0.6,"pbRate":"3.85","week52High":2.45,"institutionHeld":0,"latestPrice":0.751,"committee":-0.393728,"eps":-1.3802,"divideRate":0,"volume":86251,"delay":0,"ttmEps":-1.3802,"open":0.73,"prevYearClose":1.51,"prevWeekClose":0.7738,"prevMonthClose":0.7702,"prevQuarterClose":0.9465,"fiveDayClose":0.7892,"twentyDayClose":0.7701,"sixtyDayClose":0.954},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MIRA\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-12","symbol":"MIRA","fiscalQuarterEnding":"2026/06","expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1786507200000,"reportTimeType":"post","actualEps":-0.03},{"market":"US","date":"2026-05-14","symbol":"MIRA","fiscalQuarterEnding":"2026/03","expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1778731200000,"reportTimeType":"","actualEps":-0.03},{"date":"2026-03-31","symbol":"MIRA","type":"earning","reportTimeType":"","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1774944000000,"name":null,"time":"","dateTimestamp":1774929600000,"actualEps":null},{"market":"US","date":"2025-11-13","symbol":"MIRA","fiscalQuarterEnding":"2025/09","expectedEps":null,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1763010000000,"reportTimeType":"pre","actualEps":-1.18},{"market":"US","date":"2025-08-14","symbol":"MIRA","fiscalQuarterEnding":"2025/06","expectedEps":-0.11,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1755144000000,"reportTimeType":"post","actualEps":-0.09}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MIRA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"MIRA\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/MIRA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"MIRA","date":"2026-09-16","current":-0.521374,"percent":0.486093,"low":-15.501022,"twenty":-6.41067,"median":-3.026925,"eighty":-1.723809,"high":-0.648567,"avg":-3.979015,"sd":3.089705,"marketCap":30007972},"quantilePoints":[{"date":"2023-08-04","current":-15.501022,"twenty":-15.501022,"median":-15.501022,"eighty":-15.501022,"marketCap":109409161},{"date":"2023-08-11","current":-14.407729,"twenty":-14.826558,"median":-14.407729,"eighty":-13.088417,"marketCap":101692488},{"date":"2023-08-18","current":-13.611953,"twenty":-14.407729,"median":-13.779485,"eighty":-13.130299,"marketCap":96075752},{"date":"2023-08-25","current":-13.193124,"twenty":-14.407729,"median":-13.42348,"eighty":-13.109358,"marketCap":93119575},{"date":"2023-09-01","current":-13.137838,"twenty":-14.303022,"median":-13.371126,"eighty":-13.130299,"marketCap":92729360},{"date":"2023-09-07","current":-12.209294,"twenty":-13.9889,"median":-13.365891,"eighty":-13.071664,"marketCap":86175515},{"date":"2023-09-15","current":-7.434221,"twenty":-13.678966,"median":-13.193124,"eighty":-12.686741,"marketCap":52472141},{"date":"2023-09-22","current":-11.507289,"twenty":-13.511434,"median":-13.119829,"eighty":-11.928492,"marketCap":66366173},{"date":"2023-09-29","current":-12.263336,"twenty":-13.419292,"median":-13.046534,"eighty":-11.42538,"marketCap":70726534},{"date":"2023-10-06","current":-12.045492,"twenty":-13.402539,"median":-12.816178,"eighty":-11.507289,"marketCap":69470159},{"date":"2023-10-13","current":-7.586097,"twenty":-13.383691,"median":-12.460173,"eighty":-11.225373,"marketCap":43751419},{"date":"2023-10-20","current":-8.457473,"twenty":-13.371126,"median":-12.263336,"eighty":-10.752267,"marketCap":48776920},{"date":"2023-10-27","current":-6.022746,"twenty":-13.371126,"median":-12.209294,"eighty":-9.627991,"marketCap":34735079},{"date":"2023-11-03","current":-3.818677,"twenty":-13.36275,"median":-12.045492,"eighty":-8.098671,"marketCap":22023518},{"date":"2023-11-10","current":-3.793048,"twenty":-13.343902,"median":-11.968606,"eighty":-7.418465,"marketCap":21875709},{"date":"2023-11-17","current":-6.622011,"twenty":-13.222442,"median":-11.712319,"eighty":-5.991992,"marketCap":49959391},{"date":"2023-11-24","current":-6.405718,"twenty":-13.159952,"median":-11.404903,"eighty":-6.252529,"marketCap":48327581},{"date":"2023-12-01","current":-6.955071,"twenty":-13.133315,"median":-11.148487,"eighty":-6.405718,"marketCap":52472141},{"date":"2023-12-08","current":-3.546106,"twenty":-13.117734,"median":-10.762135,"eighty":-5.961237,"marketCap":26753401},{"date":"2023-12-15","current":-2.977946,"twenty":-13.096793,"median":-9.110163,"eighty":-5.156496,"marketCap":22466945},{"date":"2023-12-22","current":-2.066929,"twenty":-13.063287,"median":-8.611245,"eighty":-3.869935,"marketCap":15593833},{"date":"2023-12-29","current":-2.155092,"twenty":-13.025592,"median":-8.1243,"eighty":-3.839181,"marketCap":16258973},{"date":"2024-01-05","current":-2.272643,"twenty":-12.962768,"median":-7.893642,"eighty":-3.762396,"marketCap":17145826},{"date":"2024-01-12","current":-1.929591,"twenty":-12.874813,"median":-7.640782,"eighty":-3.079823,"marketCap":14557693},{"date":"2024-01-19","current":-1.608482,"twenty":-12.807801,"median":-7.444864,"eighty":-2.883906,"marketCap":12135106},{"date":"2024-01-26","current":-2.292235,"twenty":-12.642964,"median":-7.355439,"eighty":-2.366683,"marketCap":17293635},{"date":"2024-02-02","current":-1.880808,"twenty":-12.498268,"median":-7.111805,"eighty":-2.256969,"marketCap":14189649},{"date":"2024-02-09","current":-1.950359,"twenty":-12.397348,"median":-6.788541,"eighty":-2.206031,"marketCap":14714371},{"date":"2024-02-16","current":-2.01795,"twenty":-12.300188,"median":-6.405718,"eighty":-2.186439,"marketCap":15224311},{"date":"2024-02-23","current":-2.076725,"twenty":-12.241719,"median":-6.022746,"eighty":-2.135501,"marketCap":15667738},{"date":"2024-03-01","current":-1.968971,"twenty":-12.205282,"median":-5.750179,"eighty":-2.104154,"marketCap":14854789},{"date":"2024-03-08","current":-1.86102,"twenty":-12.137755,"median":-4.971969,"eighty":-2.061052,"marketCap":14040362},{"date":"2024-03-15","current":-2.409785,"twenty":-12.045492,"median":-3.957585,"eighty":-2.070847,"marketCap":18180488},{"date":"2024-03-22","current":-2.46856,"twenty":-12.014738,"median":-3.869935,"eighty":-2.084562,"marketCap":18623915},{"date":"2024-03-28","current":-2.135501,"twenty":-11.968606,"median":-3.818677,"eighty":-2.096317,"marketCap":16111164},{"date":"2024-04-05","current":-1.258227,"twenty":-11.958355,"median":-3.592948,"eighty":-2.059093,"marketCap":15076502},{"date":"2024-04-12","current":-1.209008,"twenty":-11.917349,"median":-3.095496,"eighty":-2.037542,"marketCap":14486745},{"date":"2024-04-19","current":-1.033719,"twenty":-11.835337,"median":-3.026925,"eighty":-1.978767,"marketCap":12386381},{"date":"2024-04-26","current":-1.1102,"twenty":-11.507289,"median":-2.977946,"eighty":-1.941738,"marketCap":13302796},{"date":"2024-05-03","current":-0.996589,"twenty":-11.466334,"median":-2.723253,"eighty":-1.872971,"marketCap":11941476},{"date":"2024-05-10","current":-0.925167,"twenty":-11.297339,"median":-2.546927,"eighty":-1.840684,"marketCap":11085663},{"date":"2024-05-17","current":-0.812651,"twenty":-11.251002,"median":-2.419581,"eighty":-1.782849,"marketCap":10043611},{"date":"2024-05-24","current":-1.05244,"twenty":-11.138236,"median":-2.390193,"eighty":-1.612165,"marketCap":13007178},{"date":"2024-05-31","current":-0.956764,"twenty":-11.09723,"median":-2.331418,"eighty":-1.319904,"marketCap":11824708},{"date":"2024-06-07","current":-0.922081,"twenty":-10.81147,"median":-2.30203,"eighty":-1.233679,"marketCap":11396062},{"date":"2024-06-14","current":-0.849247,"twenty":-10.732533,"median":-2.292235,"eighty":-1.18937,"marketCap":10495906},{"date":"2024-06-21","current":-0.875439,"twenty":-10.189973,"median":-2.272643,"eighty":-1.090284,"marketCap":10819607},{"date":"2024-06-28","current":-0.77737,"twenty":-9.841423,"median":-2.272643,"eighty":-1.073193,"marketCap":9607575},{"date":"2024-07-05","current":-0.687674,"twenty":-9.256415,"median":-2.262847,"eighty":-1.05424,"marketCap":8499008},{"date":"2024-07-12","current":-0.717692,"twenty":-8.841445,"median":-2.213868,"eighty":-1.045463,"marketCap":8870009},{"date":"2024-07-15","current":-0.704656,"twenty":-8.774265,"median":-2.213868,"eighty":-1.033719,"marketCap":8708897},{"date":"2024-08-02","current":-2.906169,"twenty":-8.772416,"median":-2.213868,"eighty":-1.036655,"marketCap":35917550},{"date":"2024-08-09","current":-2.535423,"twenty":-8.703509,"median":-2.262847,"eighty":-1.048424,"marketCap":31335476},{"date":"2024-08-16","current":-2.173611,"twenty":-8.390838,"median":-2.272643,"eighty":-1.04904,"marketCap":27788063},{"date":"2024-08-23","current":-2.162049,"twenty":-8.098671,"median":-2.248016,"eighty":-1.051378,"marketCap":27640254},{"date":"2024-08-30","current":-2.162049,"twenty":-7.95515,"median":-2.242981,"eighty":-1.05289,"marketCap":27640254},{"date":"2024-09-06","current":-1.826758,"twenty":-7.791127,"median":-2.23142,"eighty":-1.05469,"marketCap":23353798},{"date":"2024-09-13","current":-1.549276,"twenty":-7.650578,"median":-2.222644,"eighty":-1.05842,"marketCap":19806385},{"date":"2024-09-20","current":-1.341164,"twenty":-7.640782,"median":-2.194276,"eighty":-1.060611,"marketCap":17145826},{"date":"2024-09-27","current":-1.237108,"twenty":-7.586097,"median":-2.16783,"eighty":-1.073193,"marketCap":15815546},{"date":"2024-10-04","current":-1.352726,"twenty":-7.444864,"median":-2.155092,"eighty":-1.083185,"marketCap":17293635},{"date":"2024-10-11","current":-1.24867,"twenty":-7.434221,"median":-2.147009,"eighty":-1.095016,"marketCap":15963355},{"date":"2024-10-18","current":-1.260232,"twenty":-7.355439,"median":-2.135501,"eighty":-1.1102,"marketCap":16111164},{"date":"2024-10-25","current":-1.437761,"twenty":-7.355439,"median":-2.125705,"eighty":-1.110817,"marketCap":18380747},{"date":"2024-10-31","current":-2.79918,"twenty":-7.270245,"median":-2.125705,"eighty":-1.18937,"marketCap":35785525},{"date":"2024-11-08","current":-2.150279,"twenty":-7.139233,"median":-2.135501,"eighty":-1.21299,"marketCap":27489790},{"date":"2024-11-15","current":-2.170683,"twenty":-7.064784,"median":-2.135501,"eighty":-1.218696,"marketCap":24399222},{"date":"2024-11-22","current":-1.856409,"twenty":-6.974663,"median":-2.135501,"eighty":-1.224412,"marketCap":20866673},{"date":"2024-11-29","current":-1.90061,"twenty":-6.755235,"median":-2.115909,"eighty":-1.229612,"marketCap":21363499},{"date":"2024-12-06","current":-1.753275,"twenty":-6.551481,"median":-2.101597,"eighty":-1.233136,"marketCap":19707413},{"date":"2024-12-13","current":-1.650142,"twenty":-6.445215,"median":-2.081117,"eighty":-1.235736,"marketCap":18548154},{"date":"2024-12-20","current":-1.473341,"twenty":-6.405718,"median":-2.071827,"eighty":-1.237108,"marketCap":16560852},{"date":"2024-12-27","current":-1.768009,"twenty":-6.252529,"median":-2.060335,"eighty":-1.241733,"marketCap":19873022},{"date":"2025-01-03","current":-1.694342,"twenty":-5.991992,"median":-2.057134,"eighty":-1.250581,"marketCap":19044979},{"date":"2025-01-10","current":-1.959543,"twenty":-5.868974,"median":-2.057134,"eighty":-1.258227,"marketCap":22025933},{"date":"2025-01-17","current":-1.768009,"twenty":-5.779566,"median":-2.037542,"eighty":-1.258227,"marketCap":19873022},{"date":"2025-01-24","current":-1.664875,"twenty":-5.732546,"median":-2.035768,"eighty":-1.259831,"marketCap":18713762},{"date":"2025-01-31","current":-1.856409,"twenty":-5.367769,"median":-2.010846,"eighty":-1.260232,"marketCap":20866673},{"date":"2025-02-07","current":-1.723809,"twenty":-5.033478,"median":-1.997597,"eighty":-1.260232,"marketCap":19376196},{"date":"2025-02-14","current":-1.753275,"twenty":-4.268723,"median":-1.967235,"eighty":-1.268496,"marketCap":19707413},{"date":"2025-02-21","current":-1.635408,"twenty":-4.064306,"median":-1.959359,"eighty":-1.271301,"marketCap":18382545},{"date":"2025-02-28","current":-1.502808,"twenty":-3.940055,"median":-1.950359,"eighty":-1.271793,"marketCap":16892069},{"date":"2025-03-07","current":-1.488074,"twenty":-3.869935,"median":-1.934829,"eighty":-1.271793,"marketCap":16726460},{"date":"2025-03-14","current":-1.841676,"twenty":-3.869935,"median":-1.920187,"eighty":-1.27873,"marketCap":20701065},{"date":"2025-03-21","current":-1.797476,"twenty":-3.846869,"median":-1.893243,"eighty":-1.290292,"marketCap":20204239},{"date":"2025-03-28","current":-1.620675,"twenty":-3.823803,"median":-1.885876,"eighty":-1.294917,"marketCap":18216937},{"date":"2025-04-04","current":-1.927027,"twenty":-3.8033,"median":-1.893243,"eighty":-1.309909,"marketCap":15132288},{"date":"2025-04-11","current":-1.806267,"twenty":-3.701093,"median":-1.885876,"eighty":-1.319904,"marketCap":14183998},{"date":"2025-04-17","current":-2.291021,"twenty":-3.602316,"median":-1.885876,"eighty":-1.323783,"marketCap":17990609},{"date":"2025-04-25","current":-2.128723,"twenty":-3.467739,"median":-1.885876,"eighty":-1.330657,"marketCap":16716134},{"date":"2025-05-02","current":-2.440901,"twenty":-3.248312,"median":-1.90061,"eighty":-1.333733,"marketCap":19167565},{"date":"2025-05-09","current":-2.676427,"twenty":-3.087659,"median":-1.92061,"eighty":-1.335972,"marketCap":21017067},{"date":"2025-05-16","current":-3.015077,"twenty":-3.060231,"median":-1.929591,"eighty":-1.33782,"marketCap":23875388},{"date":"2025-05-23","current":-2.611651,"twenty":-3.060231,"median":-1.942197,"eighty":-1.340821,"marketCap":20680794},{"date":"2025-05-30","current":-2.845213,"twenty":-3.032803,"median":-1.954767,"eighty":-1.341164,"marketCap":22530296},{"date":"2025-06-06","current":-2.927246,"twenty":-3.016719,"median":-1.959543,"eighty":-1.343476,"marketCap":23179883},{"date":"2025-06-13","current":-2.649478,"twenty":-3.012039,"median":-1.970481,"eighty":-1.352726,"marketCap":20980332},{"date":"2025-06-20","current":-2.628111,"twenty":-2.999889,"median":-1.99311,"eighty":-1.352726,"marketCap":20811136},{"date":"2025-06-27","current":-2.585377,"twenty":-2.991346,"median":-2.003743,"eighty":-1.36142,"marketCap":20472743},{"date":"2025-07-03","current":-2.564011,"twenty":-2.980626,"median":-2.014046,"eighty":-1.36845,"marketCap":20303547},{"date":"2025-07-11","current":-2.564011,"twenty":-2.973678,"median":-2.023876,"eighty":-1.374721,"marketCap":20303547},{"date":"2025-07-18","current":-4.711669,"twenty":-3.002927,"median":-2.037346,"eighty":-1.385099,"marketCap":37310135},{"date":"2025-07-25","current":-4.058566,"twenty":-3.076478,"median":-2.047338,"eighty":-1.397154,"marketCap":32138433},{"date":"2025-08-01","current":-3.84864,"twenty":-3.389372,"median":-2.057134,"eighty":-1.420873,"marketCap":30476100},{"date":"2025-08-08","current":-3.195538,"twenty":-3.551253,"median":-2.064723,"eighty":-1.428551,"marketCap":25304398},{"date":"2025-08-15","current":-3.428789,"twenty":-3.546261,"median":-2.076725,"eighty":-1.436037,"marketCap":27151435},{"date":"2025-08-22","current":-3.438101,"twenty":-3.551253,"median":-2.088717,"eighty":-1.466225,"marketCap":26697041},{"date":"2025-08-29","current":-3.438101,"twenty":-3.546261,"median":-2.106877,"eighty":-1.473341,"marketCap":26697041},{"date":"2025-09-05","current":-3.388985,"twenty":-3.525507,"median":-2.115909,"eighty":-1.473341,"marketCap":26315654},{"date":"2025-09-12","current":-4.076606,"twenty":-3.546416,"median":-2.135501,"eighty":-1.477279,"marketCap":31655062},{"date":"2025-09-19","current":-3.118849,"twenty":-3.546416,"median":-2.135501,"eighty":-1.484806,"marketCap":24218030},{"date":"2025-09-26","current":-3.192522,"twenty":-3.525507,"median":-2.152685,"eighty":-1.488074,"marketCap":24790109},{"date":"2025-10-03","current":-3.290754,"twenty":-3.49704,"median":-2.155092,"eighty":-1.488074,"marketCap":25552882},{"date":"2025-10-10","current":-3.290754,"twenty":-3.487217,"median":-2.162526,"eighty":-1.49011,"marketCap":25552882},{"date":"2025-10-17","current":-4.420416,"twenty":-3.487217,"median":-2.173611,"eighty":-1.498272,"marketCap":34324767},{"date":"2025-10-24","current":-3.806469,"twenty":-3.546416,"median":-2.185002,"eighty":-1.502808,"marketCap":29557438},{"date":"2025-10-31","current":-4.424118,"twenty":-3.578069,"median":-2.201174,"eighty":-1.502808,"marketCap":34353519},{"date":"2025-11-07","current":-3.861049,"twenty":-3.670695,"median":-2.213868,"eighty":-1.502941,"marketCap":29981253},{"date":"2025-11-14","current":-3.592921,"twenty":-3.756896,"median":-2.228568,"eighty":-1.509966,"marketCap":27899222},{"date":"2025-11-21","current":-8.242291,"twenty":-3.823803,"median":-2.23142,"eighty":-1.516361,"marketCap":56532717},{"date":"2025-11-28","current":-9.035993,"twenty":-3.856085,"median":-2.234472,"eighty":-1.529328,"marketCap":61976608},{"date":"2025-12-05","current":-9.035993,"twenty":-3.871153,"median":-2.253051,"eighty":-1.547915,"marketCap":61976608},{"date":"2025-12-12","current":-8.913885,"twenty":-3.914675,"median":-2.269374,"eighty":-1.5539,"marketCap":61139087},{"date":"2025-12-19","current":-9.829695,"twenty":-4.017922,"median":-2.272643,"eighty":-1.561199,"marketCap":67420500},{"date":"2025-12-26","current":-9.646533,"twenty":-4.0559,"median":-2.289228,"eighty":-1.564688,"marketCap":66164217},{"date":"2026-01-02","current":-9.219155,"twenty":-4.092912,"median":-2.292235,"eighty":-1.576475,"marketCap":63232891},{"date":"2026-01-09","current":-9.097047,"twenty":-4.198517,"median":-2.30203,"eighty":-1.591208,"marketCap":62395369},{"date":"2026-01-16","current":-8.913885,"twenty":-4.420416,"median":-2.331418,"eighty":-1.608482,"marketCap":61139087},{"date":"2026-01-23","current":-8.791777,"twenty":-4.493832,"median":-2.353856,"eighty":-1.618236,"marketCap":60301565},{"date":"2026-01-30","current":-7.63175,"twenty":-5.033478,"median":-2.394135,"eighty":-1.620675,"marketCap":52345108},{"date":"2026-02-06","current":-6.899102,"twenty":-5.899728,"median":-2.409785,"eighty":-1.620675,"marketCap":47319978},{"date":"2026-02-13","current":-7.204372,"twenty":-6.527971,"median":-2.415958,"eighty":-1.620675,"marketCap":49413782},{"date":"2026-02-20","current":-7.357007,"twenty":-6.994254,"median":-2.434454,"eighty":-1.620675,"marketCap":50460684},{"date":"2026-02-27","current":-8.120183,"twenty":-7.204372,"median":-2.451707,"eighty":-1.624409,"marketCap":55695195},{"date":"2026-03-06","current":-7.204372,"twenty":-7.265426,"median":-2.476142,"eighty":-1.628884,"marketCap":49413782},{"date":"2026-03-13","current":-7.265426,"twenty":-7.265426,"median":-2.483724,"eighty":-1.633328,"marketCap":49832543},{"date":"2026-03-20","current":-6.227508,"twenty":-7.289848,"median":-2.50832,"eighty":-1.638966,"marketCap":42713608},{"date":"2026-03-27","current":-6.471724,"twenty":-7.265426,"median":-2.523464,"eighty":-1.64662,"marketCap":44388652},{"date":"2026-04-02","current":-6.471724,"twenty":-7.265426,"median":-2.535423,"eighty":-1.650142,"marketCap":44388652},{"date":"2026-04-10","current":-4.104629,"twenty":-7.265426,"median":-2.555697,"eighty":-1.650142,"marketCap":42862528},{"date":"2026-04-17","current":-4.225354,"twenty":-7.258834,"median":-2.564011,"eighty":-1.656035,"marketCap":44123191},{"date":"2026-04-24","current":-4.225354,"twenty":-7.231117,"median":-2.577374,"eighty":-1.664875,"marketCap":44123191},{"date":"2026-05-01","current":-4.225354,"twenty":-7.204372,"median":-2.585377,"eighty":-1.664875,"marketCap":44123191},{"date":"2026-05-08","current":-4.024146,"twenty":-7.204372,"median":-2.587897,"eighty":-1.670768,"marketCap":42022087},{"date":"2026-05-15","current":-3.923945,"twenty":-7.17995,"median":-2.606744,"eighty":-1.679608,"marketCap":40975737},{"date":"2026-05-22","current":-4.233115,"twenty":-7.130713,"median":-2.612193,"eighty":-1.679608,"marketCap":41522024},{"date":"2026-05-29","current":-4.626823,"twenty":-7.105897,"median":-2.638795,"eighty":-1.679608,"marketCap":45383853},{"date":"2026-06-05","current":-4.541141,"twenty":-7.082264,"median":-2.660161,"eighty":-1.679608,"marketCap":44543412},{"date":"2026-06-12","current":-4.112732,"twenty":-7.082264,"median":-2.670844,"eighty":-1.679608,"marketCap":40341203},{"date":"2026-06-18","current":-4.190702,"twenty":-7.082264,"median":-2.675889,"eighty":-1.679608,"marketCap":41106005},{"date":"2026-06-26","current":-3.888674,"twenty":-7.053029,"median":-2.726776,"eighty":-1.685086,"marketCap":38143448},{"date":"2026-07-02","current":-4.058324,"twenty":-6.974663,"median":-2.734945,"eighty":-1.687431,"marketCap":39807523},{"date":"2026-07-10","current":-3.941368,"twenty":-6.910296,"median":-2.756312,"eighty":-1.693077,"marketCap":38660320},{"date":"2026-07-17","current":-4.00006,"twenty":-6.87468,"median":-2.79918,"eighty":-1.694342,"marketCap":39236022},{"date":"2026-07-24","current":-3.975212,"twenty":-6.844153,"median":-2.845213,"eighty":-1.694342,"marketCap":38992294},{"date":"2026-07-31","current":-3.497107,"twenty":-6.801416,"median":-2.857082,"eighty":-1.694342,"marketCap":34302629},{"date":"2026-08-07","current":-2.905474,"twenty":-6.684004,"median":-2.866446,"eighty":-1.700426,"marketCap":28499379},{"date":"2026-08-14","current":-3.325088,"twenty":-6.568471,"median":-2.905822,"eighty":-1.707238,"marketCap":31520767},{"date":"2026-08-21","current":-3.147773,"twenty":-6.515788,"median":-2.930145,"eighty":-1.709075,"marketCap":29839883},{"date":"2026-08-28","current":-3.413745,"twenty":-6.484819,"median":-2.961995,"eighty":-1.709075,"marketCap":32361209},{"date":"2026-09-04","current":-3.278543,"twenty":-6.471724,"median":-2.991346,"eighty":-1.714975,"marketCap":31079535},{"date":"2026-09-11","current":-3.498412,"twenty":-6.447302,"median":-3.015077,"eighty":-1.720868,"marketCap":33163831},{"date":"2026-09-16","current":-3.165505,"twenty":-6.41067,"median":-3.026925,"eighty":-1.723809,"marketCap":30007972}],"updateTime":1789641882351},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"MIRA\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2668995601","title":"MIRA Pharmaceuticals Initiated at Buy by Maxim Group","url":"https://stock-news.laohu8.com/highlight/detail?id=2668995601","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668995601?lang=en_us&edition=fundamental","pubTime":"2026-09-17 23:19","pubTimestamp":1789658340,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/MIRA/analyst-ratings","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","MIRA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668967482","title":"MIRA advances Ketamir-2 Phase 2a neuropathy program","url":"https://stock-news.laohu8.com/highlight/detail?id=2668967482","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668967482?lang=en_us&edition=fundamental","pubTime":"2026-09-17 20:58","pubTimestamp":1789649919,"startTime":"0","endTime":"0","summary":"MIRA Pharmaceuticals, Inc. ( ($MIRA) ) has provided an update. On Sept. 17, 2026, MIRA Pharmaceuticals announced that its Phase 2a clinical program...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/mira-advances-ketamir-2-phase-2a-neuropathy-program?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/mira-advances-ketamir-2-phase-2a-neuropathy-program?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MIRA","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668671649","title":"Mira advances Ketamir-2 to chemotherapy-induced peripheral neuropathy","url":"https://stock-news.laohu8.com/highlight/detail?id=2668671649","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668671649?lang=en_us&edition=fundamental","pubTime":"2026-09-17 20:45","pubTimestamp":1789649153,"startTime":"0","endTime":"0","summary":"Mira Pharmaceuticals (MIRA) announced that, following review and comments from the FDA, the Phase 2a protocol evaluating Ketamir-2 in chemotherapy-...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/mira-advances-ketamir-2-to-chemotherapy-induced-peripheral-neuropathy-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/mira-advances-ketamir-2-to-chemotherapy-induced-peripheral-neuropathy-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","BK4588","BK4007","BK4585","MIRA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668296214","title":"MIRA Pharmaceuticals Submits Ketamir-2 Phase 2a CIPN Protocol for IRB Review After FDA Feedback","url":"https://stock-news.laohu8.com/highlight/detail?id=2668296214","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668296214?lang=en_us&edition=fundamental","pubTime":"2026-09-17 20:32","pubTimestamp":1789648350,"startTime":"0","endTime":"0","summary":"MIRA Pharmaceuticals submits Ketamir-2 Phase 2a CIPN protocol for IRB review after FDA feedbackMira Pharmaceuticals submitted a Phase 2a protocol for Ketamir-2 in chemotherapy-induced peripheral neuro","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260917:nNDL3JzwKz:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BN0W2V16.EUR","IE00BQXX3C00.GBP","BK4007","LU2210150020.SGD","SG9999014013.SGD","BK4588","SG9999014005.SGD","LU2095319765.USD","IE00BQXX3D17.EUR","IE00BQXX3F31.USD","MIRA","LU0314104364.USD","LU2210149790.SGD","IE00BN0W2T93.GBP","BK4585","NDAQ","IE00BGHQF748.EUR","SG9999014021.USD","SG9999014039.USD","IE00BKPKM429.USD","BK4112","BCDF","IE00BN0W2W23.USD","IE00B64PRP62.GBP","IE00B3QW5Z07.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668962936","title":"Mira Pharmaceuticals - Targets Site Initiation for Phase 2a Ketamir-2 Study in Q1 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2668962936","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668962936?lang=en_us&edition=fundamental","pubTime":"2026-09-17 20:30","pubTimestamp":1789648202,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260917:nTUA1NCPJC:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","MIRA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668962671","title":"Mira Pharmaceuticals - Submits Phase 2a Protocol for Ketamir-2 in Cipn to Irb After FDA Review","url":"https://stock-news.laohu8.com/highlight/detail?id=2668962671","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668962671?lang=en_us&edition=fundamental","pubTime":"2026-09-17 20:30","pubTimestamp":1789648202,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260917:nTUA1NCPJC:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MIRA","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668629399","title":"Mira Pharmaceuticals Advances Ketamir-2 to Phase 2a in Chemotherapy-Induced Peripheral Neuropathy (Cipn) Following FDA Review","url":"https://stock-news.laohu8.com/highlight/detail?id=2668629399","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668629399?lang=en_us&edition=fundamental","pubTime":"2026-09-17 20:30","pubTimestamp":1789648202,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260917:nTUA1NCPJC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","MIRA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668964179","title":"Mira Pharmaceuticals initiated with a Buy at Maxim","url":"https://stock-news.laohu8.com/highlight/detail?id=2668964179","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668964179?lang=en_us&edition=fundamental","pubTime":"2026-09-17 19:50","pubTimestamp":1789645815,"startTime":"0","endTime":"0","summary":"Maxim analyst Jason McCarthy initiated coverage of Mira Pharmaceuticals (MIRA) with a Buy rating and $3.50 price target Published first on TheFly –...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/mira-pharmaceuticals-initiated-with-a-buy-at-maxim-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/mira-pharmaceuticals-initiated-with-a-buy-at-maxim-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MIRA","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668961072","title":"Mira Pharmaceuticals Inc : Maxim Group Initiates Coverage with Buy Rating; Target Price $3.5","url":"https://stock-news.laohu8.com/highlight/detail?id=2668961072","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668961072?lang=en_us&edition=fundamental","pubTime":"2026-09-17 19:49","pubTimestamp":1789645750,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260917:nFWN4590KT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","MIRA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668358779","title":"Mira Pharmaceuticals Holds Annual Shareholder Meeting with 63.06% of Shares Represented","url":"https://stock-news.laohu8.com/highlight/detail?id=2668358779","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668358779?lang=en_us&edition=fundamental","pubTime":"2026-09-17 04:33","pubTimestamp":1789590828,"startTime":"0","endTime":"0","summary":"Mira Pharmaceuticals holds annual shareholder meeting with 63.06% of shares representedMira Pharmaceuticals held its 2026 annual shareholder meeting on Sept. 11, 2026.Shareholders backed the board’s s","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260916:nNDL4kfwkH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","MIRA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664567498","title":"Mira Pharmaceuticals - Targets Ind Application Submission for Mira-55 to FDA in Q1 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2664567498","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664567498?lang=en_us&edition=fundamental","pubTime":"2026-09-01 20:07","pubTimestamp":1788264464,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260901:nFWN44T0HM:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MIRA","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664215856","title":"MIRA Pharmaceuticals Advances Non-Opioid Oral MIRA-55 for Inflammatory Pain Toward IND","url":"https://stock-news.laohu8.com/highlight/detail?id=2664215856","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664215856?lang=en_us&edition=fundamental","pubTime":"2026-09-01 20:00","pubTimestamp":1788264000,"startTime":"0","endTime":"0","summary":"Positive Toxicology Results From 7-Day Rat and Dog Studies Characterize Tolerability and Inform Dose Selection for Next Phase of IND-Enabling Program, Targeting Q1 2027 IND SubmissionMIAMI, Sept.  01,","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/01/3354093/0/en/mira-pharmaceuticals-advances-non-opioid-oral-mira-55-for-inflammatory-pain-toward-ind.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","IND","MIRA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659007929","title":"Mira Pharmaceuticals Q2 2026 Net Loss Narrows to $1.21 Million; Revenue Remains no Revenue","url":"https://stock-news.laohu8.com/highlight/detail?id=2659007929","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659007929?lang=en_us&edition=fundamental","pubTime":"2026-08-13 04:27","pubTimestamp":1786566434,"startTime":"0","endTime":"0","summary":"Mira Pharmaceuticals Q2 2026 net loss narrows to $1.21 million; revenue remains no revenueMira Pharmaceuticals posted a net loss of USD 1.21 million for the quarter ended June 30, 2026, narrowing from","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nNDL9DyBgG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MIRA","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657636112","title":"Mira Pharma Reports Positive 7-Day Dog Toxicokinetic Study Results for Obesity Drug Candidate SKNY-1","url":"https://stock-news.laohu8.com/highlight/detail?id=2657636112","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657636112?lang=en_us&edition=fundamental","pubTime":"2026-08-06 20:02","pubTimestamp":1786017749,"startTime":"0","endTime":"0","summary":"Mira Pharma reports positive 7-day dog toxicokinetic study results for obesity drug candidate SKNY-1Mira Pharmaceuticals reported positive results from a 7-day repeated-dose Beagle dog study of SKNY-1","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nNDL3Ftx0B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MIRA","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656946683","title":"MIRA Pharmaceuticals Receives Nasdaq Minimum Bid Price Notice","url":"https://stock-news.laohu8.com/highlight/detail?id=2656946683","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656946683?lang=en_us&edition=fundamental","pubTime":"2026-08-01 05:33","pubTimestamp":1785533612,"startTime":"0","endTime":"0","summary":"MIRA Pharmaceuticals, Inc. ( ($MIRA) ) has provided an update. On July 27, 2026, MIRA Pharmaceuticals received notice from Nasdaq that its common s...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/mira-pharmaceuticals-receives-nasdaq-minimum-bid-price-notice?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/mira-pharmaceuticals-receives-nasdaq-minimum-bid-price-notice?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NQmain","BK4007","MIRA","LCLG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656391125","title":"Mira Pharmaceuticals Risks NASDAQ Delisting After Shares Fall Below $1 Bid Price Requirement","url":"https://stock-news.laohu8.com/highlight/detail?id=2656391125","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656391125?lang=en_us&edition=fundamental","pubTime":"2026-08-01 05:01","pubTimestamp":1785531668,"startTime":"0","endTime":"0","summary":"Mira Pharmaceuticals risks Nasdaq delisting after shares fall below $1 bid price requirementMira Pharmaceuticals received a Nasdaq notice for failing to meet the $1 minimum bid price rule after 30 str","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260731:nNDL8blR1c:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","MIRA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655080351","title":"Mira Pharmaceuticals provides update on MIRA-55, SKNY-1","url":"https://stock-news.laohu8.com/highlight/detail?id=2655080351","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655080351?lang=en_us&edition=fundamental","pubTime":"2026-07-30 21:36","pubTimestamp":1785418597,"startTime":"0","endTime":"0","summary":"Mira Pharmaceuticals (MIRA) announced continued advancement of its two preclinical programs, MIRA-55, an investigational oral non-opioid drug candi...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/mira-pharmaceuticals-provides-update-on-mira-55-skny-1-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/mira-pharmaceuticals-provides-update-on-mira-55-skny-1-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","MIRA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655872999","title":"Mira Pharmaceuticals Advances Mira-55 Toward IND-enabling Studies After Completing Exploratory Tox Dosing in Rats, Dogs","url":"https://stock-news.laohu8.com/highlight/detail?id=2655872999","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655872999?lang=en_us&edition=fundamental","pubTime":"2026-07-30 20:08","pubTimestamp":1785413331,"startTime":"0","endTime":"0","summary":"Mira Pharmaceuticals advances MIRA-55 toward IND-enabling studies after completing exploratory tox dosing in rats, dogsMira Pharmaceuticals moved two preclinical oral candidates, MIRA-55 for chronic i","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260730:nNDL3wHQ9G:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BGHQF748.EUR","SG9999014039.USD","SG9999014013.SGD","LU2210149790.SGD","IE00BN0W2T93.GBP","BK4112","LU0314104364.USD","SG9999014005.SGD","IE00BN0W2W23.USD","NDAQ","IE00B64PRP62.GBP","BK4007","LU2095319765.USD","BCDF","LU2210150020.SGD","IE00B3QW5Z07.USD","SG9999014021.USD","IE00BKPKM429.USD","MIRA","BK4585","BK4588","IE00BN0W2V16.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655687216","title":"MIRA Pharmaceuticals Progresses MIRA-55 and SKNY-1 Toward IND-Enabling Studies","url":"https://stock-news.laohu8.com/highlight/detail?id=2655687216","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655687216?lang=en_us&edition=fundamental","pubTime":"2026-07-30 20:00","pubTimestamp":1785412800,"startTime":"0","endTime":"0","summary":"Completion of 7-Day Toxicology and Pharmacokinetic Studies Advances Non-Opioid Pain Therapy and Obesity Candidate DevelopmentMIAMI, July  30, 2026  (GLOBE NEWSWIRE) -- MIRA Pharmaceuticals, Inc. (NASD","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/07/30/3335999/0/en/MIRA-Pharmaceuticals-Progresses-MIRA-55-and-SKNY-1-Toward-IND-Enabling-Studies.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2237443465.HKD","LU2237443978.SGD","LU2746668974.SGD","IND","BK4223","IE00BHPRN162.USD","LU0971096721.USD","LU2746668461.USD","IE00BKVL7J92.USD","BK4007","LU2237443549.SGD","DEA","LU2237443895.HKD","IE00B1BXHZ80.USD","LU2237443382.USD","LU0170899867.USD","LU0882574139.USD","BK4006","IE00BZ1G4Q59.USD","LU0149725797.USD","CMC","LU1363072403.SGD","LU2237443622.USD","MIRA","BK4194","IE00BFXG1179.USD","LU0267386448.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655583363","title":"Mira Pharmaceuticals Announces Annual Shareholder Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2655583363","media":"Reuters","labels":["conferences","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655583363?lang=en_us&edition=fundamental","pubTime":"2026-07-29 05:01","pubTimestamp":1785272462,"startTime":"0","endTime":"0","summary":"Mira Pharmaceuticals announces annual shareholder meetingMira Pharmaceuticals will hold its annual shareholder meeting online on Sept. 11, 2026.Shareholders will vote on electing five directors to the","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260728:nNDLc0WWtZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","MIRA"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":54,"code":"91000000","status":"200"}]}}